I reported previously (twice) about Israel’s PolyPid slow-release antibiotic bone implants. PolyPid has just been accepted into the US FDA Qualified Infectious Disease Program – a new FDA status for innovative products in the treatment of bacteria resistant to antibiotics.
http://www.globes.co.il/en/article-fda-fast-tracks-israeli-co-polypid-1001180587